Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells

Nephrology Dialysis Transplantation

Volumn 23, Issue 3, 2008, Pages 860-870

  Li, Min ^a   Hering Smith, Kathleen S ^a   Simon, Eric E ^a   Batuman, Vecihi ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; MAPK; Myeloma kidney; PACAP; Renal fibrosis; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; CYCLOSPORIN A; HUMAN SERUM ALBUMIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; IMMUNOGLOBULIN LIGHT CHAIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; OSTEOGENIC PROTEIN 1; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; BONE MORPHOGENETIC PROTEIN; CADHERIN; CALCIUM BINDING PROTEIN; CCL2 PROTEIN, HUMAN; FSP1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL AGGREGATION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KIDNEY EPITHELIUM; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MALE; MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; CELL TRANSDIFFERENTIATION; DRUG EFFECT; EPITHELIUM CELL; FIBROSIS; MESODERM; METABOLISM; MULTIPLE MYELOMA; PATHOLOGY;

BONE MORPHOGENETIC PROTEINS; CADHERINS; CALCIUM-BINDING PROTEINS; CELL AGGREGATION; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CHEMOKINE CCL2; EPITHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; INTERLEUKIN-6; KIDNEY TUBULES, PROXIMAL; MESODERM; MULTIPLE MYELOMA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 42449118069     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm670     Document Type: Article

References (50)

1. Kyle RA, Gertz MA, Witzig TE et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78: 21-33
2. Abbott KC, Agodoa LY. Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol 2001; 56: 207-210
3. Iggo N, Winearls CG, Davies DR. The development of cast nephropathy in multiple myeloma. QJM 1997; 90: 653-656
4. Haubitz M, Peest D. Myeloma - new approaches to combined nephrological-haematological management. Nephrol Dial Transplant 2006; 21: 582-590
5. Herrera GA, Joseph L, Gu X, Hough A et al. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med 2004; 128: 875-879
6. Ivanyi B. Development of chronic renal failure in patients with multiple myeloma. Arch Pathol Lab Med 1993; 117: 837-840
7. Lin J, Markowitz GS, Valeri AM, Kambham N et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol 2001; 12: 1482-1492
8. Sanders PW. A new twist in myeloma treatment. Blood 2006; 107: 413-414
9. Guan S, el-Dahr S, Dipp S et al. Inhibition of Na-K-ATPase activity and gene expression by amyeloma light chain in proximal tubule cells. J Investig Med 1999; 47: 496-501
10. Pote A, Zwizinski C, Simon EE et al. Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells. Am J Kidney Dis 2000; 36: 735-744
11. Sengul S, Zwizinski C, Batuman V. Role of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells. Am J Physiol Renal Physiol 2003; 284: F1245-F1254
12. Sengul S, Zwizinski C, Simon EE et al. Endocytosis of light chains induces cytokines through activation of NF-kappaB in human proximal tubule cells. Kidney Int 2002; 62: 1977-1988
13. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7: 2495-2508
14. Fine LG, Norman JT, Ong A. Cell-cell cross-talk in the pathogenesis of renal interstitial fibrosis. Kidney Int Suppl 1995; 49: S48-S50
15. Herzlinger D. Renal interstitial fibrosis: remembrance of things past? J Clin Investig 2002; 110: 305-306
16. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Investig 2003; 112: 1776-1784
17. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004; 15: 1-12
18. Rastaldi MP, Ferrario F, Giardino L et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002; 62: 137-146
19. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001; 159: 1465-1475
20. Zeisberg M, Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 2004; 82: 175-181
21. Batuman V, Guan S. Receptor-mediated endocytosis of immunoglobulin light chains by renal proximal tubule cells. Am J Physiol 1997; 272: F521-F530
22. Batuman V, Verroust PJ, Navar GL et al. Myeloma light chains are ligands for cubilin (gp280). Am J Physiol 1998; 275: F246-F254
23. Klassen RB, Allen PL, Batuman V et al. Light chains are a ligand for megalin. J Appl Physiol 2005; 98: 257-263
24. McMorrow T, Gaffney MM, Slattery C et al. Cyclosporine A induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. Nephrol Dial Transplant 2005; 20: 2215-2225
25. Arimura A, Li M, Batuman V. Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury. Blood 2006; 107: 661-668
26. Badid C, Desmouliere A, Babici D et al. Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction. Nephrol Dial Transplant 2002; 17: 1993-1998
27. Powell DW, Mifflin RC, Valentich JD et al. Myofibroblasts: I. Paracrine cells important in health and disease. Am J Physiol 1999; 277: C1-C9
28. Forino M, Torregrossa R, Ceol M et al. TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture. Int J Exp Pathol 2006; 87: 197-208
29. Slattery C, Campbell E, McMorrow T et al. Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. Am J Pathol 2005; 167: 395-407
30. Bruneval P, Rossert J, Bariety J. Renewal of FSP1: a marker of fibrogenesis on human renal biopsies. Kidney Int 2005; 68: 1366-1367
31. Okada H, Danoff TM, Kalluri R et al. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 1997; 273: F563-F574
32. Rossini M, Cheunsuchon B, Donnert E et al. Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease. Kidney Int 2005; 68: 2621-2628
33. Burns WC, Kantharidis P, Thomas MC. The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs 2007; 185: 222-2231
34. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006; 69: 213-217
35. Mucsi I, Rosivall L. Epithelial-mesenchymal transition in renal tubular cells in the pathogenesis of progressive tubulo-interstitial fibrosis. Acta Physiol Hung 2007; 94: 117-131
36. Fan JM, Ng YY, Hill PA et al. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999; 56: 1455-1467
37. Fan JM, Huang XR, Ng YY et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis 2001; 37: 820-831
38. Copeland JW, Beaumont BW, Merrilees MJ et al. Epithelial-to- mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation 2007; 83: 809-814
39. Bakin AV, Rinehart C, Tomlinson AK et al. p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 2002; 115: 3193-3206
40. Maack T, Johnson V, Kau ST et al. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 1979; 16: 251-270
41. Brunskill NJ. Albumin signals the coming of age of proteinuric nephropathy. J Am Soc Nephrol 2004; 15: 504-505
42. Gekle M. Renal tubule albumin transport. Annu Rev Physiol 2005; 67: 573-594
43. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456
44. Iwano M, Plieth D, Danoff TM et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Investig 2002; 110: 341-350
45. Arimura A, Li M, Batuman V. Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38. Ann N Y Acad Sci 2006; 1070: 1-4
46. Li M, Cortez S, Nakamachi T, Batuman V et al. Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells. Cancer Res 2006; 66: 8796-8803
47. Ritz E. Cast nephropathy in myeloma - does PACAP38, a new member of the vasoactive intestinal peptide family, open a therapeutic window? J Am Soc Nephrol 2006; 17: 911-913
48. Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002; 13: 96-107
49. Zeisberg M, Hanai J, Sugimoto H et al. BMP-7 counteracts TGFbeta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-968
50. Zeisberg M, Shah AA, Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 2005; 280: 8094-8100